MIRA Pharmaceuticals, Inc. (MIRA)
Last updated: 2026-10-22 08:17:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
MIRA Pharmaceuticals, Inc. (MIRA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.68, with a market capitalization of $27.32M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.60 to $1.80. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$27.32M | |
$0.67 | |
$7.98 | |
$0.51 | |
$0.65 | |
126.95K | |
596.47K | |
-- | |
$1.80 | |
$0.60 | |
-- | |
-- |
MIRA Pharmaceuticals, Inc. (MIRA) Pre-Market Stock Price
MIRA Pharmaceuticals, Inc. (MIRA) is trading at $0.65 in pre-market trading as of 2026-10-21 23:31:00, up 0.60% ($0.00) from the previous close of $0.65
Pre-market trading shows how investors are pricing MIRA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
MIRA Pharmaceuticals, Inc. (MIRA) 7-Day Stock Price Change
Over the past seven days, MIRA Pharmaceuticals, Inc. (MIRA) moved from $0.67 to $0.68, representing a gain of 2.19% ($0.01).
The stock traded between $0.62 and $0.71 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 86.04 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
MIRA 52-Week Price Position
Position in Range: 6.8%
MIRA is currently trading at $0.68, placing it 6.8% of the way from its 52-week low of $0.60 to its 52-week high of $1.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is MIRA Pharmaceuticals, Inc. (MIRA)?
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
MIRA Pharmaceuticals, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy MIRA Pharmaceuticals, Inc. (MIRA) Stock on MEXC
Eligible investors can buy real shares of MIRA Pharmaceuticals, Inc. (MIRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is MIRA Pharmaceuticals, Inc. (MIRA) stock price today?
2.Is MIRA stock going up or down today?
3.What is MIRA pre-market price?
4.What is MIRA after-hours price?
5.Is MIRA stock trading now?
6.Where does MIRA sit relative to its 52-week high and low?
7.What sector is MIRA Pharmaceuticals, Inc. in?
8.What is MIRA Pharmaceuticals, Inc.'s market capitalization and where is it listed?
9.How is MIRA valued in terms of P/E ratio and EPS?
10.Does MIRA Pharmaceuticals, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MIRA Stock Calculator
Estimate the value between MIRA shares and USD.
MIRA Shares to USD
1.00 MIRA shares = 0.681 USD
Calculations are estimates based on the latest available price and are for reference only.


